What is Two Chairs?
Founded in 2017, Two Chairs operates at the intersection of behavioral health and advanced technology. The company distinguishes itself through a proprietary matching algorithm designed to pair clients with the most suitable therapists, facilitating both virtual and in-person treatment modalities. By prioritizing the therapeutic alliance, Two Chairs addresses the critical need for personalized mental health care in an increasingly fragmented market. Its operational model emphasizes clinical quality and patient outcomes, positioning the firm as a leader in the modern mental health landscape.
How much funding has Two Chairs raised?
Two Chairs has raised a total of $107.5M across 4 funding rounds:
Multiple Rounds
$35.5M
Series C
$72M
Series A (2019): $7M with participation from Maveron
Series B (2019): $21M led by Goldcrest, Maveron, and Amplo
Other Financing Round (2019): $7.5M supported by Tam Holdings, Makers Fund, and Taubman Capital
Series C (2024): $72M featuring Amplo and Fifth Down Capital
Key Investors in Two Chairs
Maveron
Maveron is a consumer-only venture capital firm that partners with innovative entrepreneurs to transform consumer experiences and industries. The firm focuses on investing in early-stage consumer brands that prioritize human behavior and technological disruption.
Fifth Down Capital
Fifth Down Capital partners with extraordinary individuals building the future, focusing on venture and growth-stage companies that leverage technology to solve massive societal problems.
Makers Fund
Makers Fund is a global venture capital fund focused on supporting the next generation of creators and innovators in the games and interactive entertainment industry.
What's next for Two Chairs?
With the infusion of $72M, Two Chairs is well-positioned to accelerate its national expansion and enhance its technological capabilities. The strategic focus will likely shift toward deepening its integration with enterprise health systems and refining its matching engine to improve patient retention and clinical efficacy. As the company scales, it faces the dual challenge of maintaining high-touch clinical standards while managing the complexities of a multi-state healthcare operation. Investors are clearly betting on the firm's ability to capture significant market share by solving the persistent problem of therapist-patient compatibility at scale.
See full Two Chairs company page
